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Heart valve disease is currently one of the leading forms of heart disease. Current
literature has shown that endothelin I, angiotension II and 5-HT are vasoactive agents
which cause concentration dependent contractions in aortic valve leaflet tissue. This
study tested the mechanical properties of leaflets cut in the radial direction after they
were exposed to the agents at varied concentrations or for 0.5, 6 or 24 hours. The elastic
modulus, ultimate tensile strength and the yield strength were calculated. In the time
trials the elastic modulus and the ultimate tensile strength both showed a significant
increase at 24-hours. However, there were no significant differences found between the
concentrations. Indicating the amount of vasoactive agent is not as significant as the
length of exposure.

ACKNOWLEDGEMENTS
I would like to thank Dr. James Warnock, Dr. Steve Elder, Dr. Gary McFadyen,
and Mr. Andy Whetstone for serving as my thesis committee. Their insight and expertise
were invaluable to this project. I would also like to thank Mr. Randy Williams and Sara
Lee Foods for the fresh supply of heart valves, Scott Metzler for tirelessly proofreading,
Shelly Sharma for her assistance in running the experiments, Lakeisha Williams for her
insight and help in running the mach 1 machine as well as the rest of Dr. Warnock’s
research group who have offered scientific as well as moral support. I would also like to
thank my husband, Wade, for his wonderful support and encouragement in this endeavor.

ii

TABLE OF CONTENTS
Page
ACKNOWLEDGEMENTS ..........................................................................

ii

LIST OF TABLES .......................................................................................

vi

LIST OF FIGURES ......................................................................................

vii

CHAPTER
I. INTRODUCTION, BACKGROUND AND SIGNIFICANCE ....

1

Heart Physiology.........................................................................
Heart Valves ...............................................................................
Mechanical Properties of the Aortic Valve ..................................
Physical Properties of the Aortic Valve .......................................
Structure of Aortic Heart Valve Leaflets......................................
Disease and Disorders of Aortic Heart Valves .............................
Hypertension...............................................................................
Endothelin I.................................................................................
Angiotension II ...........................................................................
5-HT ...........................................................................................
Significance ................................................................................

1
2
4
9
12
15
16
17
18
19
20

II. HYPOTHESIS AND SPECIFIC AIMS.......................................

22

III. METHODS AND MATERIALS.................................................

24

Specific Aim I .............................................................................
Rationale .....................................................................................
Experimental Design ...................................................................
Expected Results .........................................................................
Specific Aim II............................................................................
Rationale .....................................................................................
Experimental Design ...................................................................

24
24
24
29
29
29
30

iii

CHAPTER

Page

Data Analysis ..............................................................................
Anticipated Outcomes .................................................................

31
37

IV. RESULTS ...................................................................................

38

Specific Aim I .............................................................................
Elastic Modulus.....................................................................
Ultimate Tensile Strength ......................................................
Specific Aim II............................................................................
Elastic Modulus.....................................................................
Ultimate Tensile Strength ......................................................
Yield Strength .............................................................................
Hemotoxylin and Eosin Stains.....................................................

41
41
45
51
51
54
57
57

V. DISCUSSION.............................................................................

66

Specific Aim I .............................................................................
Elastic Modulus.....................................................................
Ultimate Tensile Strength ......................................................
Specific Aim II............................................................................
Elastic Modulus.....................................................................
Ultimate Tensile Strength ......................................................
Summary.....................................................................................
Limitations..................................................................................
Future Research...........................................................................

66
66
68
69
69
70
71
72
72

REFERENCES.............................................................................................

74

APPENDIX
A. STRESS STRAIN CURVES FOR CONTROL ........................

79

B. STRESS STRAIN CURVES FOR ANGIOTENSION II ..........

81

C. STRESS STRAIN CURVES FOR ENDOTHELIN I................

92

D. STRESS STRAIN CURVES FOR 5-HT .................................. 103
E. TIME DEPENDENT STRESS STRAIN CURVES FOR
CONTROL........................................................................ 114
F. TIME DEPENDENT STRESS STRAIN CURVES FOR
ANGIOTENSION II.......................................................... 118
iv

APPENDIX

Page

G. TIME DEPENDENT STRESS STRAIN CURVES FOR
ENDOTHELIN I ............................................................... 122
H. TIME DEPENDENT STRESS STRAIN CURVES FOR
5-HT.................................................................................. 126

v

LIST OF TABLES
TABLE
1

Page

Leaflets and Corresponding valves.............................................................

25

2 The Concentrations of Endothlin I which yielded significantly different
ultimate tensile strengths. .................................................................

47

3 The Concentrations of 5-HT which yielded significantly different ultimate
tensile strengths.................................................................................

50

vi

LIST OF FIGURES
FIGURE

Page

1 Human Cardiac Flow ................................................................................

2

2 Dissected Aortic Valve with Leaflets Visible .............................................

3

3 Stress vs. Strain .........................................................................................

6

4 Sections of the Stress Strain Curve ..........................................................

8

5 The Components of the Aortic Root...........................................................

10

6 Closed Aortic Valve ..................................................................................

11

7 The Three Layers of Leaflets ....................................................................

12

8 A Normal Heart and Ventricle Hypertrophy due to Hypertension ..............

16

9 Compression Foot for Measuring Thickness ..............................................

26

10 Alligator Clips Used for Tension Testing ...................................................

27

11 Sandpaper and plastic used to secure sample. .............................................

28

12 Elastic Modulus from Stress Strain Curve ..................................................

32

13 Calculation of Total Stress .........................................................................

33

14 Trendline at 0.2% Strain ............................................................................

34

15 Yield Strength............................................................................................

35

16 Calculation of Ultimate Tensile Strength....................................................

36

17 Sample Data Graph..................................................................................

39

vii

FIGURE
18

Page

A Sample in Tension as it approaches failure. ..........................................

40

19 Elastic Modulus vs. Concentration of Endothelin I ....................................

42

20 Elastic Modulus vs. Concentration of Angiotension II ...............................

43

21 Elastic Modulus vs. Concentration of 5-HT ..............................................

44

22 Ultimate Tensile Strength vs. Concentration of Endothelin I ....................

46

23 Ultimate Tensile Strength vs. Concentration of Angiotension II ................

48

24 Ultimate Tensile Strength vs. Concentration of 5-HT ................................

49

25 Elastic Modulus vs. Time ET-1 .................................................................

51

26 Elastic Modulus vs. Time ANG II .............................................................

52

27 Elastic Modulus vs. Time 5-HT . ...............................................................

53

28 Ultimate Tensile Strength vs. Time ET-1 . .................................................

54

29 Ultimate Tensile Strength vs. Time ANG II . .............................................

55

30 Ultimate Tensile Strength vs. Time 5-HT ..................................................

56

31 Sample after 6hours of Exposure to KCl ....................................................

58

32 Sample after 6 hour Exposure to Endothelin I ............................................

59

33 Sample after 6hours of exposure to Angiotension II ...................................

60

34 Sample after 6hours exposure to 5-HT .......................................................

61

35 Sample after 24 hours of exposure to KCl ..................................................

62

36 Sample after 24 hour exposure to Endothelin I ...........................................

63

37 Sample after 24 hours exposure to Angiotension II ....................................

64

38 Sample after 24 hours exposure to 5-HT ....................................................

65

viii

CHAPTER I
INTRODUCTION,
BACKGROUND AND SIGNIFICANCE

Heart Physiology
The four chambers of the heart serve to move deoxygenated blood to the lungs for
oxygenation and send oxygenated blood through the body. Blood enters the atria, passes
through the mitral and tricuspid valves into the left and right ventricles, respectively, and
exits through the aortic and pulmonary valves (1). The right side of the heart supplies the
force to direct blood flow through the pulmonary valve into the lungs. Oxygenated blood
returns to the heart through the left atrium and exits the left ventricle into the systemic
circulation through the aortic valve. The flow of blood through the heart is shown in
Figure 1.

1

Figure 1 Human Cardiac Flow
(www.medicinenet.com)
Heart Valves
Heart valves function to control the directional flow of blood through the heart.
The aortic, pulmonary, and tricuspid valves are comprised of three leaflets or cusps while
the mitral valve is bicuspid, or composed of two leaflets. The leaflets open and close to
allow the passage of blood, stop regurgitation and prohibit back flow.
The anatomy and function of the tricuspid and mitral valves are very similar (2).
Likewise, the aortic and pulmonary valves exhibit the same similarities. Both the aortic
and pulmonary, or semilunar, valves (3) are responsible for directing the flow of blood
out of the heart. The mitral and tricuspid valves, or the atrioventricular valves (4),
contain chordal attachments, which aid in the opening and closing of the valves. The
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semilunar valves lack these chordal attachments (5) and the ability to independently
contract (6). The aortic valve is instead supported by the aortic root (7). Aortic valvular
leaflets attach to a fibrous ring surrounding the entrance to the aorta, leaving the outer
edges of the leaflets unrestrained (6). Observations of the leaflet configuration lead to the
assumption that the leaflets rotate along the attachment sight. Movement is achieved by a
combination of shearing and bending. This is achieved in part by the collagenous fibers
bound by hydrated glycosaminoglycan molecules which promote slippage (8). Figure 2
shows an aortic valve with the leaflets exposed.

Figure 2 Dissected Aortic Valve with Leaflets Visible
(heartlab.robarts.ca/ dissect/dissection2.html)
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Mechanical Properties of the Aortic Valve
A great deal of time has been spent researching the mechanical properties of heart
valves in order to create a better artificial valve and understand the circumstances which
can cause damage to native valves. One study has shown that the load-bearing portion of
the leaflet acts as a cylinder under stress, thus determining the way calculations are
conducted for the samples in vivo (9). For this reason membrane stress in the leaflet in
the radial direction is calculated as (PR/2t) where P is pressure, R is radius and t is the
thickness of the collagenous layer (8). Calculations done in this manner can be used to
correspond with a stress strain curve developed from measurements made in vitro (9).
Current literature provides a wide range of data for each of the mechanical
properties. There are several sources for these differences. One factor affecting the
outcome is the type of valve used. Studies have suggested that porcine valves yield
higher strain rates than do canine valves (9). Differences between the transition strains in
two studies have been as much as 40%. However, comparisons with another study
showed comparable results for both the canine and fresh porcine valves (9). Further
comparison is needed to determine if the species of animal being tested makes a
significant difference on the mechanical property values.

Testing has shown that

xenografts are significantly stiffer than fresh porcine valves and native valves, or
allografts. The same study found that there was no significant difference in the elastic
moduli and the strain at the point of transition for allograft and fresh porcine valves (10).
This suggests that fresh porcine valves can be used to produce results similar from native
human valves.
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Testing in vivo also produces different results than unaxial, in vitro testing (9). In
vitro testing allows the leaflet to be tested in only one direction while in vivo allows the
leaflet to undergo forces in both the circumferential and radial direction (9). As the
sample is tested in vivo the stress in the radial direction is offset by the pulling together of
circumferential collagen cords by the circumferential stress.

The tightening of the

collagen cords prevents the cords from separating and therefore reduces stress in the
radial direction (9). Comparisons of incremental strains suggest that the leaflets have an
increased ability to stretch in vitro rather than in vivo (9). Incremental strains for the
entire valve have been found to have a systolic average of 14.9% in vivo and 9.6% in
vitro and a diastolic average of 3.9% in vivo and 8.7% in vitro in canines (9).
Another factor that influences the outcome of mechanical testing is the difference
between fresh and frozen valves (11). Freezing the valves cause a general stiffening of
the tissue. The frozen valves are no longer able to elongate in the radial direction under
low stress. The freezing process also changes the elastic modulus both initially and
following transition as well as the point of transition (11). The difference between fresh
valves and xenografts mechanical properties suggest that cryopresevation has a negative
effect on the mechanical properties of the valve leaflets, especially of the collagen fibers
(10).
Another factor which affects the results of a test is the direction which is being
tested (12). Mechanical testing in the circumferential direction produces stiffer results
than testing in the radial direction (12). Figure 7 shows the difference that can occur
between radially and circumferentially tested frozen and fresh valves.
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Figure 3 Stress vs. Strain

Radially and Circumferentially Tested Frozen and Fresh Valves (11)

Between systole and diastole the radial length increases by 30.8% and the
circumferential by 10.9% in canines (8). This change in length occurs under the same
stresses for each sample. Since the circumferential elongation is smaller, the elastic
modulus will be higher indicating a stiffer material. During diastole the membrane stress
in the circumferential direction is 85.4 g/mm2 and in the radial 40.6 g/mm-2 (8). This
shows that circumferential testing of the membrane stress yields higher stress than in the
radial direction while the total stress ranges from 37 to 44 g/mm2 in the radial direction in
canines (8). This shows that while testing in the circumferential direction gives stiffer
results, samples tested radially undergo much less stress.
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Throughout the cardiac cycle the total stress throughout the leaflet is tensile (13).
The radial length of leaflets changes as the cardiac cycle progresses with the largest
change occurring between systole and diastole. The average length increase was 30.8 ±
3%. This increase in length was constant in the presence of increasing systolic pressure
and diastolic pressure. Increases in systolic pressure yielded limited effects on the length
of the leaflets perhaps because there was no pressure gradient applied to the leaflet (9).
In diastole, the pressure gradient and the leaflet length maintain a very sensitive
relationship. Along with length the thickness must also be determined, with average
leaflet thickness ranging between 0.4 and 0.5 mm (14). The thickness of the lamina
fibrosa varies from 0.063 and 0.170 mm with the total stress in diastole measured
between 75.8 and 95 g/mm2. In systole the total stress in negligible because of the low
modulus of elasticity (8). The stress in the lamina fibrosa is close to the total amount
measured for the leaflet suggesting that lamina fibrosa withstands a large portion of the
stress for the leaflet. In another study the elastic modulus in systole was found to be 2.4
± 0.7 x 106 dynes/ cm2 and in diastole 5.2 ± 1.7 x 107 dynes/ cm2 (14). The higher elastic
modulus in systole indicates a stiffer material than the lower elastic modulus measured in
diastole.
The stress also varies with the surface on which it is measured. Stress on the
aortic surface in the circumferential direction range in systole from 4 to 9 g/mm2, and in
diastole from 9 to 15 g/mm2 and on the ventricular surface the circumferential stress
ranged from systole from 0.3 to 0.8 g/mm2 to diastole from 36 to 75 g/mm2 (13). This
indicates that the layers of the leaflet undergo different responses to the application of
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force. This is expected because of the differences in makeup of the layers and also
direction of movement in the valve.
Despite the range of values which have previously been described, each method
of testing provides similar stress strain curves. One author breaks the stress strain curve
into four distinct parts (11). Figure 8 shows the way that the line is divided.

Figure 4 Sections of the Stress Strain Curve (11)

The first portion of the graph (A) undergoes low levels of stress with larger
amounts of elongation. In this portion of the graph the collagen fibers begin in a wavy
pattern which is quickly stretched out with low levels of stress (12). This elastic portion
of the graph has a low elastic modulus which corresponds with systole (14). In systole,
the leaflet is in an elastic phase with small changes in pressure gradient but large changes
8

in length (9). The next portion of the graph (B) is the transition phase. In this portion of
the graph the elastic modulus undergoes a sudden change as the sample becomes stiffer
(11). This corresponds with the collagen fibers reaching their full length and therefore
more force being required to elongate the fibers (12). Transition strain is the strain
between the areas of high and low elastic modulus (9). After the transition phase the
sample begins to stiffen (C) (11).

This inelastic stiffening produces a high elastic

modulus and corresponds with diastole (14). In diastole, the leaflet is in an inelastic
phase with small length changes associated with large pressure changes (9). The final
portion of the graph (D) is rupture which occurs after 100 to 200 percent elongation.
Rupture is also shown to occur from 500 to 1,000 psi (11). Another study of the
elasticity of human valve cusps shows elastic behavior up to 10% increase in length, past
that point all behavior is inelastic (15).
The area which undergoes the most stress is the attachment zone.

In the

attachment zone movement takes place through a combination of bending and shearing
(8). The thickness at the site of leaflet attachment commissures is between 1.79 and 2.55
mm while the thickness at the leaflet bases was between 1.53 and 2.38 mm (8). Bending
strain at the commissures was 2.18% and at the base 2.61% (8). The elastic modulus is
proportional to the flexion rigidity of the leaflet (9).

Physical Properties of the Aortic Valve
As recently as 1980 the opening and closing of the aortic valve was attributed to
the fluctuations in pressure gradients across the valve (13). Since then the dynamic
structure of the valve has been discovered and studied (16). The entire aortic root, not
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just the leaflets, works together to control blood direction and flow properties. The
sinuses, aortic valve leaflets, commissures and the interleaflet triangles compose the
aortic root (7). Figure 3 shows the aortic root with the above-mentioned structures
labeled.

c

c

d

d

Figure 5 The Components of the Aortic Root:
(a) the interleaflet triangles, (b) the valve leaflets, (c) the sinuses and (d) the commissures

As the cardiac cycle progresses, dynamic changes occur in the component parts of
each valve, including the aortic root, in order to prepare the valve for the movement of
blood (2). The aortic root supports the valve leaflets in the left ventricular outflow tract
(7). During systole, the aortic root displaces downward and returns to a neutral position
during diastole (17). This movement allows the valve to dilate and constrict forcing the
10

flow of blood. Disorders and diseases involving the aortic root can cause dilations which
have been cited as a cause of death (18).
Along with position of the components, the valve undergoes changes in shape
prior to blood flow (16). Theses changes include a progression in the shape of the aortic
orifice (2). As the cardiac cycle progresses the aortic orifice morphs from a closed valve
to a triangular opening and finally to an open circle (2). The sequence of opening occurs
without flexion deformities occurring in the leaflets (2). Figure 4 shows an aortic valve
which is completely closed.

Figure 6 Closed Aortic Valve
(http://www.incardiology.gr)

Aortic root variations correspond with changes in the leaflets.

The leaflets

reverse their circumferential curvature during the opening and closing of the valve (13).
In addition, independent contraction occurs in the valves due to innervations of the
leaflets (6).
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Structure of Aortic Heart Valve Leaflets
Leaflets are chiefly composed of connective tissue more specifically collagen (8).
They are composed of three layers with some structural similarities (12). The layers of
the leaflet are the fibrosa, spongiosa and the ventricularis. Figure 5 displays the three
layers of the leaflet.

Figure 7 The Three Layers of Leaflets (17)

The lamina fibrosa, the layer facing the aorta (19), is comprised of collagen and
elastin saturated with water (12). Elastic fibers are composed of an insoluble amorphous
core of elastin (20). In the lamina fibrosa the collagen runs parallel to the free edge. The
fibrosa and ventricularis, the side facing the left ventricle, are both composed of elastin
and collagen. The fibrosa and ventricularis both undergo changes is shape during the
cardiac cycle in times of low strain the ventricularis dominates the elastic response. Then
12

for a time the layers share the responsibility and finally in times of high stress the fibrosa
dominates the elastic process (19). The spongiosa or middle layer is comprised of
proteoglycans and a loose thick layer of collagen (8, 21) as well as elastic fibers and
glycoprotiens which are components for the cellular matrix (4).

Scanning electron

microscope (SEM) images show that the network of the extra cellular matrix (ECM) is
waved and uniaxially aligned (12). The waviness that occurs in the ECM has a great
effect on the response of the valve to force. At low stresses the leaflet expands quickly as
the collagen and elastin become straight and the force required to elongate the fibers
greatly increases (12). This change in the force required allows the leaflet to produce
greater elongations and movements with less stress.
Valve leaflets undergo approximately 3 billion cycles of potentially damaging
stresses in a lifetime (9). The leaflets are equipped to withstand the cardiac cycles with
elastic properties and the ability to regenerate (14). The pattern of strain and stress
contribute to a higher renewal rate in the tissue of the leaflets (8). Loading, unloading
and flexion are experienced predominately in the area of attachment. Cyclic changes are
noted to reduce the creep and flexion in the leaflet. During diastole the leaflets undergo
stiffening (9) and the leaflet opening decreases during systole (14). During diastole the
fibrosa shrinks while the ventricularis expands and vice versa in systole (14).
Interstitial cells populate the interior of the leaflet (22) which is covered on both
sides by endothelial cells (4). Interstitial cells include myofibroblasts, fibroblasts and
smooth muscle cells (23).

Myofibroblasts, which are up to 60% of the interstitial

population (23), share characteristics with fibroblast and smooth muscle cells (4, 24).
Myofibroblasts exhibit non-muscle and muscle proteins, contractile properties and secrete
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the extracellular matrix (4). The contractile properties are used to protect damaged areas
of the heart (23). The characteristic displayed depends upon the organ and orientation in
which the cells are found. Myofibroblasts display a diverse phenotype and are highly
plastic as are fibroblasts (24). Myofibroblasts serve another role as the prominent load
bearing cells involved in proliferation and migration and contractile properties (4). This
is supported by evidence that the genes necessary for contraction are expressed in the
interstitial cells (23) and the presence of smooth muscle α-actin in the fibers (24).
The fibroblasts are characteristically elongated cells which produce a swirling
pattern when confluent (4). Mutations of the extracellular matrix have a disastrous effect
on the valve function (20). Fibroblasts remodel the extracellular matrix which allows for
longer function and durability (24).

They are prominent in synthetic and secretory

organelles and synthesize collagen.
Smooth muscle interstitial cells share similar characteristics to smooth muscle
cells exhibit communication junctions, bundles of actin filaments, innervations and
contraction in response to epinephrine and angiotension II (22). The communication or
gap junctions serve to propagate stimuli among the interstitial cells (22).
Endothelial cells cover the valve leaflets also line entire blood system and adjust
in number easily (25). However the vascular and valve endothelial cells are different
sub-phenotypes. Endothelial cells are continuous with the surrounding endocardium (4).
Injury to endothelial cells can be the first step in pathological conditions (4).
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Disease and Disorders of Aortic Heart Valves
Due to time and/or disease, dysfunctions may develop in the heart valves (2, 17,
26 , 27). The majority of valve disorders present similar physiological manifestations (2).
These manifestations include tethering, deformation, calcification and/or thickening,
retraction, fusion, stretching, dilation or rupture (2).
Valvular disorders are generally classified as stenosis, regurgitation or a
combination of the two. Stenosis is caused by the valve not opening fully, obstructing
the blood flow; regurgitation occurs when the valve does not close completely resulting
in reverse blood flow. Stenosis due to calcification of the valve is the most common
dysfunction of the aorta. As ectopic calcification disease progresses the leaflets are
unable to fully open, thus requiring greater levels of pressure to pass the blood through
the valve (28). The occurrence and continued progression of the stenosis is linked to an
inflammatory response (2). Abnormal lipid profiles and hypertension have been cited as
potentially playing a significant role in valve dysfunction (29). Progression of the disease
leads to left ventricular hypertrophy (30) and requires surgery to either repair or even
replace the valve (31). The increase in the left ventricle mass for a continued period of
time can cause the left ventricle to fail (30, 32). Failure of the left ventricle leads to death
within one year (30). Researchers hope to one day use information about the specific
causes of valve dysfunction to treat the dysfunction by non-invasive means (2). Figure 8
shows a normal heart and one with ventricle hypertrophy due to hypertension.
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Figure 8 A Normal Heart and Ventricle Hypertrophy due to Hypertension
(www.usnews.com/.../ articles/051029/28book.htm)

Hypertension
An evaluation of past studies has shown a correlation between aortic valve
sclerosis and hypertension (33). Today approximately on third of the population of
industrialized countries live with hypertension (34).

Hypertension is caused by an

increase in blood pressure due to a narrowing of blood vessels; this can be caused either
by blockage (e.g. atherosclerosis) or by contraction of the blood vessels (26). When the
contraction or blockage creates systolic pressure greater than 140 mm Hg or diastolic
pressure greater than 90 mm Hg the patient is considered to have hypertension (34).
Hypertension can be broken down into two groups, essential (95%) and
secondary (5%)

(27). Causation is the main difference between them.

Secondary

hypertension has a known pathology, while the cause for essential is unknown (35). The
complications associated with hypertension are life altering and often life threatening.
Complications include peripheral vascular disease, coronary artery disease, cerebral
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vascular accident, cardiovascular renal failure and transient ischemic attacks. The renal
system yields a two-fold role in the presence of hypertension. Renal failure can be cited
as both a cause and result of hypertension (26, 35). The damaged kidney’s inability to
excrete excess fluid and salt causes a decrease in rennin. The decrease in rennin in the
rennin- angiotension system allows the presence of hypertension to increase (35).
The effect of hypertension on the body is not purely mechanical.

Vascular

remodeling has been linked to hypertension; however the exact mechanisms are not fully
understood (36). Increased production of vasoactive agents occurs in the presence of
hypertension. Endothelin I and angiotension II increase in production but are also a
cause of hypertension. Contraction of the heart valve leaflets has been linked to these
agents as well as 5-HT (37).

Endothelin I
One study suggests that endothelin I may serve a regulatory role in tension of the
cusp (38). Experimental evidence also suggests that increased levels of endothelin I
affects the competence of valves (2), due to the fact that endothelin I is a potent mitogen,
induces mitosis, in the cardiovascular system (37). Positive stains for immunoreactive
endothelin were discovered on the fibrosa and the ventricularis endothelial cells (38).
This in not surprising since endothelin I is an endothelium derived vasoconstrictor (39).
The effect of endothelin I one is greater on pericardium cells than interstitial cells (23).
Endothelin I causes concentration dependent contractions which take 5 to 10
minutes to reach the maximum level (38). Contractions increase the tension in leaflets
which in turn change the coordinated movements of the leaflets (38). Endothelin I shows
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regional differences in reaction in the circumferential direction (39). Circumferentially,
the contraction increased in response to endothelin I (39). Radially, there is a significant
reduction in contraction in comparison to the entire cusp in the presence of Endothelin I
(39). These differences may be enough to regulate changes in the valve shape and size
throughout the cycle (39). In equine valves endothelin I caused contraction of all of the
valves tested even at 10 nM (37). The contractions can be linked to a rise in intracellular
calcium in human interstitial and rabbit endothelial cells (24, 38).
Endothelin I has a higher contraction and potency response than angiotension II or
5-HT (24, 40). In addition, endothelin I induces a higher magnitude of contraction in
leaflets (40). According to one study, endothelin I may have the ability to enhance the
effect of 5-HT (40). However, contrary to studies on other animals, endothelin I is less
potent than angiotension II in equine valves (37).

Angiotension II
Interstitial cells are presumed to be the only cells responsible for the contraction
associated with angiotension II (22), a potent mitogen in the cardiovascular system (37).
Angiotension II causes an increase in functional activation of interstitial cells by
increasing calcium levels (41). It also effects systemic hemodynamics, blood volume and
sodium excretion; and is in turn influenced by sodium intake (42). Sodium levels,
angiotension II and blood pressure all respond to one another and determine the amount
of damagee done to organs (43). Angiotension II has also been found to induce cell
hypertrophy (44). The agent also causes a concentration dependent increase in collagen
synthesis (41). However, it failed to produce concentration dependent contractions (40).
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In equine valves these contractions were measured at levels as low as 0.3nM (37).
In one study a combination of 10-6M epinephrine and 10-5M angiotension II
reached a plateau in 10 minutes and a decrease in response after 20 minutes (22). The
long plateau suggests a tonic contraction (22). The response may be phenotypically
related (37). In the body, angiotension II is broken down to several active fragments
(42). One of these Angiotension – (1-7) actually acts opposite of angiotension II to stop
the effect of the contractions (42).
In studies angiotension II has been found to be more powerful than 5-HT in
stimulating collagen production (41).

In equine valves, angiotension II is a potent

contractile agent, but with varied results as many as 25 % of the subjects were nonresponsive (37). In equines which have some of the same heart conditions as humans the
angiotension II was found to be more potent than endothelin I or 5-HT (37).

5-HT
5-hydroxytryptamine, 5-HT, or serotonin (45) is produced in the enterochromaffin
cells in the intestine, pulmonary neuroendocrine and nueroepitheial bodies in the airways
and stored in platelets (46). By increasing calcium levels, 5-HT increases the functional
activation of interstitial cells (41). A marked increase in 5-HT is found in the presence of
either primary or secondary pulmonary hypertension (46). 5-HT has been associated
with fenfluramine and phentermine, appetite-suppressing drugs, which alter the level of
brain uptake of the vasoactive agent (41). The agent has been linked to valve disease in
those taking appetite suppressing drugs (16) and a potential role in memory formation
(45).

Phentermine and fenfluramine were at one time prescribed together as the
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‘fen/phen’ drugs for weight loss (46).

Phentermine inhibits 5-HT metabolism thus

increasing levels of 5-HT in the blood and increase the vasoconstrictor effects (46).
Fenfluramine induces valvular heart disease and increases the amount of 5-HT circulation
in the body (46). Dexfenfluramine, a form of fenfluramine, can decrease the amount of
5-HT taken up by the forebrain (46).
A study of a static in-vitro model has shown that only cusp tissue contracts in
response to 5-HT (16). Experimental data supports the concept that the contractions in
turn compromise the competence of the valve (2). Competence can be affected by the
changes in geometry, thus, proper opening and closing of the valve, in response to 5-HT
(40). Even small contractions of the leaflets produce a significant influence on valve
leakage (16). Higher concentrations of 5-HT increased the amount of leakage in the
valves (16). The contraction may be in part caused by the increase in tissue fibrosis
promoted by 5-HT (41).

5-HT also produced concentration dependent increases in

collagen production (41) and smooth muscle cell proliferation (46). However, in equine
valves 5-HT showed no contraction but a decrease in basal tone or resting tone (37). One
study suggests that 5-HT is a potent mitogen in cardiovascular system (37).

The

mitogenic effects in another study were significant but variable, weak and potentially
yielding results over longer periods of time (41).

Significance
In 2003 it was estimated that 34.2% of the American population had some form of
cardiovascular disease (34). Over one third of heart conditions are associated with
diseased valves and 60% of these occur in the aortic valve. (30) One of the risk factors
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implicated in the pathogenesis of valves is hypertension (35). Estimates predict that
approximately 30% of industrialized societies will develop hypertension by the age of 65
(26, 34). Estimated total cost annually for hypertensive disease exceeds sixty five billion
dollars. The direct costs include the cost for care and procedures, indirect cost consist of
lost wages and morbidity, among others. Angiotension II, Endothelin I, and 5-HT are
vasoactive agents associated with hypertensive effects on the aortic heart valve leaflets
(2). These agents cause contractions of the valve interstitium. The changes caused by
the vasoactive agents are known to affect valve competence (2). Studies involving 5-HT
have demonstrated that the presence of agent the valve begins to leak (16). Along with
leaks the contraction of the leaflets has the potential to stiffen the leaflets. Stiffening of
the leaflets can lead to an abundance of functional problems in the heart itself and would
cause notable changes in the mechanical properties of the valves. Currently it is not
known how much the mechanical properties change in response to the vasoactive agents.
Knowing how much the properties change and at what concentration the agents have an
affect will provide healthcare professionals with some of the required knowledge to treat
the affects of the agents before they become life threatening.
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CHAPTER II
HYPOTHESIS AND SPECIFIC AIMS
The valve interstitium is populated by fibroblast and smooth muscle cells. Three
vasoactive agents known to cause vascular smooth muscle cell contraction are endothelin
I, angiotension II and 5-hydroxytryptamine (5-HT).

These agents will affect the

biomechanical properties of leaflets by causing contractions in the fibroblast and smooth
muscle cells. Studies suggest that angiotension II and 5-HT may have larger effects due
to time rather than concentration (41). The current study proposes that the ultimate
tensile strength, elastic modulus, and yield strength, will increase with exposure to
vasoactive agents in a dose and time dependent manner. To test this hypothesis the
specific aims of this study are:
1. Determine the effect of the concentration of vasoactive agents on the mechanical
properties of aortic valve leaflets.
Strips of valve tissue, cut in the radial direction, will be incubated with
angiotension II or 5-HT for thirty minutes at concentrations ranging from 10-5M to 10-9M.
Strips will also be incubated with endothelin I at concentrations ranging from 10-7M to
10-11M. The stress and elongation of the tissue will then be measured using the Mach 1
machine and the strain, elastic modulus, ultimate tensile strength and yield strength
calculated.
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2. Evaluate the mechanical properties of aortic valve tissue following prolonged exposure
to vasoactive agents.
Valve leaflet tissue will be incubated in endothelin I, angiotension II or 5-HT for
either 6 or 24 hours. Following exposure, stress/strain data will be acquired using the
mach 1 machine, and used to asses changes in the force applied and the resulting
elongation of the tissue. Calculations of strain, elastic modulus, ultimate tensile strength
and yield strength will be made from the measured data.
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CHAPTER III
METHODS AND MATERIALS
Specific Aim I
Determine the effect of the concentration of vasoactive agents on the mechanical
properties of aortic valve leaflets.

Rationale
It has been previously shown that the concentration of angiotension II, endothelin
I and 5-HT has an affect on the contraction of aortic valve leaflets (16). Additionally,
increased cellular contraction is known to increase the flexural stiffness of the leaflets
(47). The effects of vasoactive agents at the molecular level has been well documented
(38, 40, 42, 45), however there is no existing analysis of the stress, strain, elastic modulus
or stiffness calculated from the leaflet stress strain curve. This portion of the study will
test these mechanical properties of the valves after exposure to different concentrations of
vasoactive agents.

Experimental Design
Porcine aortic heart valves were supplied by a local slaughterhouse (Sara Lee
Foods, West Point, MS). The valves were transported back to the laboratory in ice-cold
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Krebs-Ringer solution (Sigma, St. Louis, MO). The leaflets were removed and cut into
radial strips using two razor blades separated by 3mm spacers. The strips underwent a
30-minute incubation period at 37oC in Krebs-Ringer solution to ensure a uniform
starting temperature. One leaflet from each valve was tested with each vasoactive agent
being used in a trial. Table 1 shows how the leaflets were placed into the six well plates
ensuring that one leaflet from each valve and two leaflets from each position was tested
with each agent. The leaflets are labeled L, R, and N for left, right or non-coronary
respectively.

Table 1 Leaflets and Corresponding valves
Ang II

ET-1

5-HT

Valve 1

L

R

N

Valve 2

L

R

N

Valve 3

N

L

R

Valve 4

N

L

R

Valve 5

R

N

L

Valve 6

R

N

L

The leaflets were submerged in 3mL of Krebs in a six well plate for the 10-6M and
10-5M test. For the 10-7M test 5mL of Krebs was used so that 0.5 µL of the stock solution
could be added in order to achieve the desired molarity. A stock solution of each agent
was prepared at a concentration of 10-3M and diluted so that 0.5µL could be added to
5mL of Krebs to gain 10-8M, 10-9M, 10-10M and 10-11M. 30 µL of this solution was
added to the Krebs-Ringer solution to produce a 10-5M solution. Likewise, 3 µL was
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added to produce a 10-6M solution. The samples that were tested at 10-7M received the
addition of 0.5 µL of stock solution, the minimum measurable amount with available
pipettes. The endothelin I concentration tests were conducted in one day due to the quick
deterioration of the agent in solution. The endothelin I tests will be conducted at smaller
concentrations due its ability to effect the contraction of the leaflets in quantities as low
as 10-9 M where as angiotension II and 5-HT did not exhibit similar amounts of
contraction (40). A set of negative controls were also run. A 90mM solution of KCl was
added for 30 minutes to six samples and then the mechanical properties were measured.
The leaflet tissue has been shown to contract in the presence of KCl allowing KCl to act
as a control in this experiment (16).
Each sample remained submerged in the appropriate vasoactive agent for 30
minutes. The thickness of the sample was measured using the Mach 1 micro mechanics
machine using the set up pictured in figure 9.

Figure 9 Compression Foot for Measuring Thickness
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The thickness was used to calculate the cross sectional area and in turn the stress.
The compressor foot was first lowered until it touched the bottom plate. The machine
was then calibrated to this position. Next, the sample was placed onto the bottom plate
and the compressor foot lowered until it made contact with the sample registering a 0.1g
load. The y output provided the thickness of the sample. Next the 1kg load cell was
fitted with the fabricated fittings shown in figure 10. Small strips of sand paper were
added to each side of the sample in order to allow for a more even distribution of the
force figure 11 shows the sandpaper.

Figure 10 Alligator Clips Used for Tension Testing
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Figure 11 Sandpaper and plastic used to secure sample.

The sample was first stretched to its full length under 1g of load without any
recording being made. Next, the sample underwent sinusoidal stretching of 100 µm for
10 cycles at 10 µm a second. This ensured that the true properties of the samples were
tested and took into account changes which may have occurred due to a relaxation on
normal stresses and strains on the sample. The sample was then stretched at 10 µm/s
until failure. While the second sample was being tested to failure, vasoactive agents were
added to the next set of samples. This allowed time for the final 4 samples to be tested
and the fixtures on the load plate to be changed out.
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Expected Results
It was expected that higher concentrations of the vasoactive agents would produce
increased stiffening in the leaflets, since the higher concentrations have produced greater
amounts of contraction in the leaflets (40). It was also expected that endothelin I would
produce the greatest degree of stiffening and would be noticeable at 10-9 M
concentrations. This was expected because endothelin I produced contractions at levels
as low as 10-9M while 5-HT and angiotension II did not produce notable contractions
(40).

Specific Aim II
Evaluate the mechanical properties of aortic valve tissue following prolonged
exposure to vasoactive agents.

Rationale
Angiotension II and 5-HT have both been shown to promote prolonged collagen
synthesis in aortic valves (41). It has not been determined if this increase in collagen
synthesis will produce changes in mechanical properties.

Therefore, this aim

investigates the changes in the biomechanics of leaflet tissue following prolonged
exposure to Ang II or 5-HT. Due to its effectiveness at 10-9M endothelium I will also be
assessed to determine its effect over time.
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Experimental Design
The procedure for the 6 and 24-hour test was the same as the 30-minute test
except for a few minor changes. The samples were prepared in the biological safety
cabinet to insure sterility of the sample. Also all media and equipment were handled
aseptically. All samples were placed in 5mL of Krebs’s solution so that 0.5 µL of stock
solution could be added to each well to produce an IC50.

IC is the inhibitory

concentration or the concentration which produces a definite inhibition. IC50 is the
concentration which produces fifty percent of the total inhibition. In this study the IC50
was the concentration that caused fifty percent of the total change in mechanical
properties. The IC50 for ET-1, ANG II and 5-HT were 10-9M, 10-7M, and 5*10-7M
respectively. Another difference is that the 6-hour test was conducted in one day and the
24-hour test was conducted in two days. In addition, the samples were incubated in
solution for a longer period of time. For the first test the leaflets were submerged in
solution of each agent for 6 hours and 24 hours for the second test. The vasoactive agents
were added to the sets of samples in 45-minute intervals. This allowed time for the
samples to be removed from incubation, the thickness measured, the 10 cycle testing and
testing to failure occur as well as changing the fixtures on the Mach 1 machine to
alternate between the compression and tension testing. Prior to completing the tension
test the samples were examined to check for viability of the sample. The viability was
determined based on a histological analysis.
In order to conduct a histological analysis the histological sections must be cut.
These sections were cut in the radial direction just as all of the samples for testing have
been prepared. The samples were then placed in formalin for 24 hours. The formalin

30

fixed soluble proteins to structural proteins. Next the samples were dehydrated where
alcohol replaces all liquids in the tissue. Then the samples underwent clearing where the
alcohol was removed from the sample with a clearing agent.

After the alcohol is

removed the sample was infiltrated with paraffin wax. The samples were then embedded
in paraffin to provide the necessary support (48). Once the samples had been properly
preserved they were cut into 5µm sections using a microtome. The sections were placed
on slides to allow for staining.
In order to stain the samples removal of the paraffin was necessary. This was
achieved by treating the sample with xylene to remove the wax and alcohol to remove the
xylene (48).

Once the paraffin was removed the section was treated with alum

haematoxylin and washed in 1% alcohol. At this point the nucleus was red. A wash with
tap water was then conducted and changed the nucleus from red to blue (48). Finally the
eosin was added and the specimen examined under 400-x magnification.

Data Analysis
After each set of test are completed the stress and strain of each sample was
calculated and plotted in a stress strain curve. The stress was calculated by dividing the
change in gage length by the initial gage length. The strain was calculated by dividing
the force by the cross sectional area. The stress strain curve was used to calculate the
elastic modulus. The elastic modulus was calculated by finding the slope of the linear
portion of the stress strain curve. The pink region in figure 12 is the elastic modulus.
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Stress vs. Strain Sample 2
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Figure 12 Elastic Modulus from Stress Strain Curve
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A trendline was then plotted through the elastic modulus and the equation displayed.
From the equation the x intercept was calculated. The total strain for the inelastic region
was calculated by subtracting the x-intercept from the maximum strain. Figure 14 shows
the calculation of the total strain

Stress vs. Strain Angiotension II
-6
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Figure 13 Calculation of Total Stress
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Next, 0.2% of the total strain was calculated. A trendline at 0.2% strain was
plotted using the slope of the curve at 0.2% strain. Figure 15 shows the trendline at 0.2%
strain in yellow and the elastic modulus in pink.
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Figure 14 Trendline at 0.2% Strain
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Linear (0.20%)

The point of stress where the 0.2% trendline crosses the stress strain curve is the
yield strength. This point was determined by limiting the x and y-axis so that the exact
point where the trendline crosses the stress strain curve can be determined. Figure 16
show the point at which the trendline crosses the stress strain curve. The black arrow
refers to the intersection of the samples stress strain curve and the 0.2% strain trendline.
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Figure 15 Yield Strength
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Linear (Elastic Modulus)

Linear (0.20%)

The ultimate tensile strength was obtained from the stress strain curve. The
ultimate tensile strength is the highest stress that the sample withstands.

It was

determined by adjusting the y-axis so that the highest stress undergone can be measured.
Figure 17 shows the location of the ultimate tensile strength of the sample.

Figure 16 Calculation of Ultimate Tensile Strength
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The calculated results for the samples were ranked and compared as a ratio to the
ranked results of KCl.

Statistical comparisons of the ranked ratios were used to

determine if the concentration and/or exposure time had any significant effect on the
mechanical properties of the leaflets. An ANOVA TEST, p-=0.05, was conducted to
determine if the set or results had any statistical analysis. If any statistical difference was
found then a paired t-test, p=0.05 compared the concentrations or times. The analysis
determined if there is a significant difference between the measurement for increasing
concentrations or increased exposure time.

Anticipated Outcomes
It is expected that the 24-hour test of angiotension II will provide the greatest
effect on stiffness. This is based on the finding that angiotension II is more powerful
than 5-HT (41). It is also based on the information that endothelin I acts very quickly
while angiotension II is known to take a longer time before its full effects are seen. It has
been shown that angiotension II does not produce contractions in valve leaflets (40), but
it does produce a concentration dependent increase in collagen synthesis (41). Over time
this increase in collagen production will lead to an increase in the stiffness of the valve
leaflets themselves.
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CHAPTER IV
RESULTS
In this study radial samples of porcine aortic heart valve leaflets were exposed to
varied concentrations of vasoactive agents.

Samples were also placed in one

concentration of the agent for a varied length of time.

The samples were then

mechanically tested and the stress, strain, elastic modulus, ultimate tensile strength and
yield strength calculated. The following results are based off of the stress strain curves
calculated for each sample tested.
The initial stress strain curves maintain a similar shape to those described by
Clark (11). There exists a small toe region at very low stress, an increase in slope with
the addition of stress, a stiffening and finally rupture as seen in Figure 18. While rupture
did occur in all samples, it was not a clean and sudden rupture. Instead the collagen
fibers in the leaflets snapped individually producing an irregular downward slope in the
stress strain curves. These fibers could not be seen with the naked eye, but as the sample
grew thinner, very small strings of fiber could be observed.
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Figure 17 Sample Data Graph

Figure 19 shows a sample as it approaches failure. Note the presence of only a
thin string of fibers at the point of failure. This region of the graph was removed and not
used for analysis in this study, because it is past the point of initial failure. The points that
were removed did not provide an accurate example of the response of the leaflet as a
whole. The stress strain curves for the tested samples can be found in the appendixes AH. All graphs of mechanical property results are shown relative to the KCl.

39

Figure 18 A Sample in Tension as it approaches failure.

In the concentration dependent testing the samples did not show any signs of
degradation or contamination. Signs that the samples are contaminated or degraded
include cloudiness of the Krebs solution, discoloration of the sample and a change in the
appearance of the sample. The samples had a tendency to roll up in solution exposing the
ventricularis. Since this is the direction of the natural curvature of the leaflet, the rolling
up of the samples maybe in response to the lack of tension in the radial or circumfrential
direction. At six hours the tendency to roll up was gone and the samples proved to be
very flexible. However, there was no sign of degradation or contamination. At twentyfour hours, the samples once again displayed tendency to roll up. Cloudiness of the
Krebs’s solution was also noted, indicating that the samples were contaminated or
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degraded. Either contamination or degradation has the potential to affect the mechanical
properties of the leaflets. The KCl was clear, while the endothelin I had a slightly cloudy
appearance. The 5-HT was cloudier than the endothelin I but not as cloudy as the
angiotension II. The edges of these samples also were not as clearly defined when
originally cut. Instead the edges appeared to be less compacted as if some changes had
taken place. To be sure if the samples were contaminated, a microscopic examination was
necessary. The results calculated from these samples corresponded to the structure seen
in the Hand E slides, indicating that the results were based off of the mechanics of the
leaflet.

Specific Aim I
Elastic Modulus
The average elastic modulus for KCl was 2.39±1.29 (g/mm2). The values of the
elastic modulus for KCl were used to calculate ratios comparing the elastic modulus for
the vasoactive agent and the KCl.

An ANOVA test was performed to provide the

statistical analysis and determine what if any significant differences existed between the
samples.
Figure 20 displays the elastic modulus by concentration for endothelin I. The
ANOVA test indicated that no statistical difference existed between the samples.
Therefore no further statistical analysis was performed. However, the relative samples
also produced considerable error bars for the samples at 5 x 10-10, 5 x 10-9 and 10-8.
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Figure 19 Elastic Modulus vs. Concentration of Endothelin I
Samples were tested after 30 minutes of exposure to endothelin I. Expressed as a ratio
with KCl
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Figure 21 displays the relative elastic modulus for angiotension II by
concentration.

An ANOVA test indicated that there was no significant difference

between the concentrations of angiotension II. Since no significant difference was found
by the ANOVA TEST the elastic modulus of the samples is considered equivalent and no
further statistical analysis was performed. The samples tested at 10-5 yielded a high
average elastic modulus. This elastic modulus was 290% of the KCl elastic modulus
which was used as a control. The samples at 10-5 also produced unusually large error
bars.
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Figure 20 Elastic Modulus vs. Concentration of Angiotension II
Samples were tested after 30 minutes of exposure to angiotension II. Expressed as a ratio
with the KCl
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Figure 22 displays the relative elastic modulus of 5-HT by concentration. An
ANOVA test indicated that there was no significant difference between the
concentrations. Therefore, no other statistical analysis was conducted and the elastic
modulus at the different concentrations is considered equivalent.

As with the

angiotension II the sample at 10-5 produced a higher elastic modulus that the remaining
concentrations. In this instance the error bars are also considerably larger than the
remainder of the concentrations. 5- HT also produced three concentrations which had
higher elastic moduli than the KCl control.
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Figure 21 Elastic Modulus vs. Concentration of 5-HT
Samples were tested after 30 minutes of exposure to 5-HT. Expressed as a ratio with the
KCl
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Ultimate Tensile Strength
The average ultimate tensile strength of the KCl samples was 78.25±32.48g/mm2.
From this the relative ultimate tensile strength for each agent is calculated. An ANOVA
test then is used to determine what if any statistical difference exists between samples.
Figure 23 displays the ultimate tensile strength of endothelin I by concentration.
An ANOVA test indicates that there is a significant difference between the
concentrations. Therefore a paired t-test was conducted comparing each concentration to
all of the other concentrations. The results of these t-tests can be seen in Table 2. It is
interesting to note that the lower concentrations yielded were significantly different from
all of the other concentrations.

In general no consistent trend could be found to

determine a repeatable consistent effect of the concentrations on the ultimate tensile
strength of the samples. 10-10 and 5 x 10-10 both have ultimate tensile strengths higher
than that of KCl. Error bars as large as 43% are also noted for the concentrations.
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Figure 22 Ultimate Tensile Strength vs. Concentration of Endothelin I
Samples were tested after 30 minutes of exposure to endothelin I is expressed as a ratio
with the KCl
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Table 2 The Concentrations of Endothelin I which yielded significantly different ultimate
tensile strengths.

“X” indicates significant difference.

ET-1 5e-7 1e-7 5e-8 10-8 5e-9 1e-9 5e-10 1e-10 5e-11 1e-11
5e-7
1e-7

X
X

5e-8
10-8

X
X

X
X

X

X
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

5e-9

X

X

1e-9

X

X

X

X

X

X

X

1e-10

X

X

X

X

5e-11

X

5e-10

1e-11

X

X

X

X

X

X

X

X
X

X

X
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X
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Figure 24 displays the relative ultimate tensile strength for angiotension II by
concentration. An ANOVA test on the samples indicates that there is no significant
difference between the samples.

For this reason no other statistical analysis was

conducted. The large error bars should also be noted. The average error for these
samples is 25%.
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Figure 23 Ultimate Tensile Strength vs. Concentration of Angiotension II

Samples were tested after 30 minutes of exposure to angiotension II is expressed as a
ratio with the KCl
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Figure 25 displays the ultimate tensile strength of 5-HT by concentration. An
ANOVA test indicates that there is a significant difference between the concentrations.
Paired t-test were conducted between each concentration and the all the other tested
concentrations. The results of the t-test are provided in table 3. From the t-test it can be
determined that the ultimate tensile strength at 5x10-8, 10-8 and 10-9 are significantly
different from the other samples. This corresponds with the fact that the samples at 10-7
through 5x10-5 all fall below 100%, while the other samples are between 100 and 200%.
This was not expected among the lower concentrations.
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Figure 24 Ultimate Tensile Strength vs. Concentration of 5-HT

Samples were tested after 30 minutes of exposure to 5-HT is expressed as a ratio with the
KCl
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Table 3 The Concentrations of 5-HT which yielded significantly different ultimate tensile
strengths.
“X” indicates significant difference.
5-HT

5e-5

1e-5

5e-6

5e-5

1e-6

5e-7

1e-7

X

1e-5
5e-6
1e-6

X
X

X

5e-7
1e-7

X

5e-8

X

X

10-8

X

X

5e-9
1e-9

X

X

X

X

X

X

5e-8

10-8

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
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X

X

X

X

X

X

X

X

1e-9

X

X

X

5e-9

X

X
X

X
X

Specific Aim II
Elastic Modulus
Figure 26 displays the relative elastic modulus for ET-1 with respect to time. An
ANOVA test indicated that the elastic modulus was significantly different between the
0.5, 6 and 24 hour test. A paired t-test, p = .05, revealed that the elastic modulus at 0.5
and 6 hours was significantly different from 24 hour. A paired t-test also indicated that
there is no significant difference between the 0.5 and 6-hour test. In all three of the test
the sample were more than 100% of the control. The samples each produced high errors
ranging from 48 t0 66%.

300%

*

Elastic Modulus Relative to KCl (%)

250%

200%

150%

100%

50%

0%
0.5

6

24

Time of Exposure to Vasoactive Agents (Hour)

Figure 25 Elastic Modulus vs. Time ET-1
Samples were exposed to 10-9M Concentrations of endothelin I for 0.5, 6 and 24 hours. *
= p<0.05
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Figure 27 displays the time dependent elastic modulus of angiotension II. An
ANOVA test indicated that there was a statistical difference between the time dependent
samples of angiotension II. Therefore paired t-tests were conducted. The paired t-test
indicated a significant difference between the samples at 0.5 and 6 hours and the samples
at 24 hours of testing. No significant difference was found between the samples at 0.05
and 6 hours.
140%

*

Elastic Modulus Relative to KCl (%)

120%

100%

80%

60%

40%

20%

0%
0.5

6

24

Time of Exposure to Vasoactive Agent (hour)

Figure 26 Elastic Modulus vs. Time ANG II
Samples were exposed to 10-9M Concentrations of angiotension II for 0.5, 6 and 24
hours.
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Figure 28 shows the elastic modulus of 5-HT by time. An ANOVA test indicated
that there is a significant difference between the time dependent samples exposed to 5HT. A paired t-test indicated that the samples at 0.5 and 6 hours yielded an elastic
modulus significantly different from the samples at 24 hours. No significant difference
was found between the samples at 0.5 hours and 6 hours.
90%

*
80%

Elastic Modulus Relative to KCl (%)

70%

60%
50%
40%

30%
20%
10%

0%
0.5

6

24

Time of Exposure to Vasoactive Agent (Hour)

Figure 27 Elastic Modulus vs. Time 5-HT
Samples were exposed to 10-9M Concentrations of 5-HT for 0.5, 6 and 24 hours.
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Ultimate Tensile Strength
Figure 29 shows the relative ultimate tensile strength by time of endothelin I. An
ANOVA test of the calculated UTS shows that a statistical difference exists between the
samples.

Paired t–test indicated that the ultimate tensile strength at 24 hours was

significantly higher that the ultimate tensile strength at 0.5 or 6 hours. The ultimate
tensile strength at 6 hours was significantly lower than the ultimate tensile strength at 0.5
or 24 hours.

Ultimate Tensile Strength Relative to KCl (%)

250%

*

200%

*

150%

*
100%

50%

0%
0.5

6

24

Time of Exposure to Vasoactive Agent (Hour)

Figure 28 Ultimate Tensile Strength vs. Time ET-1
Samples were exposed to 10-9M Concentrations of endothelin I for 0.5, 6 and 24 hours.
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Figure 30 shows the ultimate tensile strength vs. time of exposure of angiotension
II. An ANOVA test indicated that a significant difference existed between the time trails.
A paired t-test indicated that a significant difference existed between each of the samples.
The ultimate tensile strength at 6 hours is significantly lower than the other two trials;
while the ultimate tensile strength at 24 hours is significantly higher than the trials at 0.5
and 6 hours.
200%
180%

Ultimate Tensile Strength Relative to KCl (%)

*

*

160%
140%
120%
100%

*
80%
60%
40%
20%
0%
0.5

6

24

Time of Exposure to Vasoactive Agents (Hour)

Figure 29 Ultimate Tensile Strength vs. Time ANG II
Samples were exposed to 10-9M Concentrations of angiotension II for 0.5, 6 and 24
hours.
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Figure 31 displays the ultimate tensile strength by time of 5-HT. An ANOVA test
indicated that a significant difference exist between the samples. A pair t-test revealed
that like the endothelin I and the angiotension II the samples at 24 hours had a
significantly higher ultimate tensile strength while the test at 6 hours had a significantly
lower ultimate tensile strength.
180%

*

160%

Ultimate Tensile Strength Relative to KCl (%)

*
140%

120%

100%

*
80%

60%

40%

20%

0%
0.5

6

24

Time of Exposure to Vasoactive Agent (Hour)

Figure 30 Ultimate Tensile Strength vs. Time 5-HT
Samples were exposed to 10-9M Concentrations of 5-HT for 0.5, 6 and 24 hours.
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Yield Strength
The yield strength proved to be inconclusive. The yield strength was calculated
for each sample. However the trendline at 0.02% strain crossed the stress strain curve
after the beginning of failure. By the very definition of yield strength, these results were
unacceptable. Yield strength is considered to be the point where the material goes from
exhibiting inelastic behavior to elastic behavior. This change in behavior was not noted
in the samples tested. Because so few of the samples exhibited true yield strength, no
trend or statistical difference could be calculated.

Hemotoxylin and Eosin Stains
The Hemotoxylin and Eosin (H and E) stains yielded some interesting results. In
general, a decrease in the collagen present was noted in the samples treated for six hours.
This decrease was also present with a disruption of the layers of the leaflets. At the
twenty-four hour interval the collagen was again present in the samples, but the layers of
the leaflets were no more defined than after 6 hours of exposure.

The following

explanations review each agent after six hours and twenty-four hours of exposure.
Figures 32-35 show the samples after 6hours of exposure to the vasoactive agents.
Figure 32 displays the sample after 6 hours of exposure to KCl. Some formation of the
layers still remains in this sample. The collagen can also be seen. However, it is not in
the linear pattern which is associated with the structure of the leaflets.
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Figure 31 Sample after 6hours of Exposure to KCl
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Figure 33 shows a sample after six hours of exposure to endothelin I. In this sample the
three layers of the leaflet are less defined than in the KCl sample. In addition, the
degradation of the collagen can also be noted.

Figure 32 Sample after 6 hour exposure to Endothelin I
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Figure 34 shows a sample after six hours of exposure to angiotension II. In this
sample the three layers are not easily distinguished. However, collagen fibers can still be
seen in a disorganized fashion.

Figure 33 Sample after 6hours of exposure to Angiotension II
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Figure 35 shows a sample after six hour exposure to 5-HT. This sample has the
most distinguished collagen fibers. The fibers can be noted running parallel to one
another on the left hand side of the pictures. However, as they approach the center of the
picture the structure dissipates.

Figure 34 Sample after 6hours exposure to 5-HT
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Figure 36-39 show the samples after 24-hour exposure to the vasoactive agents.
Figure 36 is a sample after twenty-four hour exposure to KCl.

In this the further

degradation of the sample can be noted. The layers of the leaflet are undeterminable but
in the bottom left corner the parallel fibers of collagen can be seen.

Figure 35 Sample after 24 hours of exposure to KCl
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Figure 37 shows a sample after twenty-four hours of exposure to endothelin I. In
this picture you can see the collagen which has increased in amount over the samples at 6
hours. However it is much wavier than is expected.

Figure 36 Sample after 24 hour exposure to Endothelin I
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Figure 38 shows a sample after twenty-four hours of exposure to angiotension II.
The layers of the sample remain undefined and the collagen matrix appears to be
damaged.

Figure 37 Sample after 24 hours exposure to Angiotension II
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Figure 39 shows a sample after twenty-four hours of exposure to 5-HT. The
collagen is more present than in the six-hour samples. The uniform structure is still not
as advanced as is seen in native samples. Also note the increase in the waviness of the
sample.

Figure 38 Sample after 24 hours exposure to 5-HT

65

CHAPTER IV
DISCUSSION

Specific Aim I
Elastic Modulus
Due to the documented contractions of the samples an increased elastic modulus
was expected to occur with increased concentrations (2, 38, 41). However this increase is
not found due to concentration. Instead the elastic modulus for each concentration of
endothelin I, angiotension II and 5-HT can be assumed equal to the other concentrations.
Since the vasoactive agents used have been known to cause some structural changes to
the leaflets due to concentration it was thought that this increase in contraction may have
a clear and profound effect on the mechanical properties of the valves. However this
clear effect has not been observed as a part of this study. From this we can conclude that
concentration does not affect the elastic modulus of the leaflet in the radial direction. It
can also be concluded that the concentration dependent contractions do not affect the
elastic modulus of the leaflets.
In these tests the samples at 10-5 were not used for evaluation because they were
extreme outliers or not within one standard deviation of the average. The entire test run
in this battery of tests yielded abnormally high results. One possible explanation is
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biological variation. Biological variation is the effect that the age, weight, health and
other such factors can have on the samples themselves. This is most probably the major
cause of differences between the concentrations. However it does not fully explain the
increased elastic modulus in the samples treated with 10e-5 concentrations. Biological
variation may play an important role in the differences but they are more appropriately
attributed to experimental design. Since all of the samples run on this day are extreme
outliers, one possible rationale for these results is contamination. Contamination of the
samples could cause altered mechanical properties. The introduction of other chemicals,
bacteria, or agents can produce a biological response in the samples, just as the
vasoactive agents. If the presence of the secondary substances is unknown, then the
leaflets may display changes in mechanical properties induced by another substance.
Another potential cause of the unusual response is the length of time which the samples
were being prepped for testing. Since this was the first day that the samples were run, it
took longer to cut the leaflets and get them into solution. During this time the samples
were at room temperature, and then placed in a 37oC incubator. These changes in
temperature would cause changes in the rate of degradation. Once a biological tissue is
taken from its natural environment it begins to decompose. At proper conditions the
tissues, or individual cells can be maintained. However, room temperature is not the
optimum temperature for maintaining the viability of porcine leaflets. One other possible
source of the larger elastic modulus is that there was no sandpaper used to evenly
distribute the force across the sample. In reality the combination of these factors could be
the cause of the extreme outliers.
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Ultimate Tensile Strength
The concentration did not seem to affect the ultimate tensile strength of the
samples. It was expected that as the concentration increased, that the ultimate tensile
strength would also increase.

Since the agents induce concentration dependent

contractions, it was thought that the increased contraction would produce a higher
ultimate tensile strength. It was thought that the concentration dependent increase in
collagen synthesis caused by angiotension II (40) would allow it to undergo higher loads.
However, no significant pattern was found, with either an increase or decrease in the
trend of the ultimate tensile strength. This could be because the maximum stress that the
leaflet can undergo in any circumstance has already been achieved in the failure testing.
This could also be because the collagen is responsible for the ultimate tensile strength and
is unaffected by the agent concentration. 5-HT and Ang II have both been shown to
initiate collagen synthesis, but in 30 minutes the increase in collagen synthesis will not be
significant enough to affect the mechanical properties. This is further supported by the
observation that each sample as it neared failure dwindled to only a thread like portion of
collagen. At this point the load exhibited increased to between 70 and 75 grams. This
was consistent without regard to the time of exposure or the concentration.
According to the ANOVA test and t-test significant differences occurred between
the concentrations treated with endothelin I and 5-HT. However, no trend was seen in
the significantly different concentrations. In fact a spike in the ultimate tensile strength at
some concentrations was noted. There are two possible reasons for these spikes. One is
biological variation. No valves will produce exactly the same results under the same
conditions; there will be some variation of the results. Another possible explanation lies
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in the experimental design. If some portion of the experiment allowed for variations due
to procedure rather than the biological function of the valve, then the results would be
altered as is seen in these two graphs. One possible explanation is that the samples
slipped in the sandpaper, or the sand paper slipped against the plastic pieces which were
added to the alligator clips. This did not appear to happen, but if the slipping occurred on
a small scale it would not be readily detected by the eye, but it would alter the results.
Specific Aim II
Elastic Modulus
The elastic modulus due to time was significantly different, but did not exhibit the
expected trend. It was thought that the samples would stiffen with each increment of
time.

Instead the elastic modulus remained equivalent for 0.5 and 6 hours.

The

significant difference occurred at 24 hours. There are two possible solutions for the
difference seen in the samples. One is that the agents have not had sufficient time to
affect the mechanical properties at 6 hours but have been able to initiate the synthesis of
collagen at 24 hours.

Another explanation is that as time progresses the collagen

synthesis continues, but the natural breakdown of the collagen progresses at a faster rate
leading to the degradation of the collagen seen in the H and E slides. This natural
breakdown of the collagen is accomplished by matrix metallo proteinases (MMPs). As
time progresses, the rate of collagen synthesis increases faster than the rate of
degradation.

This causes the more ordered sturcture seen in the 24-hour H and E

samples. Since collagen is considered to maintain the mechanical properties of the
leaflets, this increase is why the elastic modulus of the samples increased at 24 hours.
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Ultimate Tensile Strength
The time of exposure did have a significant effect on the ultimate tensile strength
of the samples. It was originally thought the ultimate tensile strength would increase
with time of exposure. However the samples at six hours have a lower ultimate tensile
strength than the other two time trails. The samples have comparable thicknesses no
matter the treatment. The thickness at 6 hours was slightly lower than the thicknesses at
0.5 hours and 24 hours. More importantly there was a drop in the load at the first signs of
failure. In the 0.5 hour and 24 hour test the first signs of failure occurred between 60 to
70g loads. In the 6 hour test the first signs of failure occurred between 30 to 40g load.
This allows for the lower ultimate tensile strength at 6 hours. This can be explained by
the process of the collagen breaking down and then being resynthesized as described in
the discussion of the elastic modulus for specific aim I. As the collagen was broken
down at 6 hours the amount of load that the sample could withstand before the beginning
of failure was reduced from the amount of load that the samples with intact collagen
could withstand. When this reduced load was divided by an equivalent thickness the
result was a lower ultimate tensile strength. This further supports the idea that the
collagen is responsible for maintaining many of the leaflets mechanical properties. In the
absence of the intact collagen the load bearing properties of the leaflet are no longer
maintained. In all three vasoactive agents, the lower ultimate tensile strength occurred at
6 hours with the significant increase in elastic modulus at 24 hours makes the
significance of the effect of time of exposure appear much greater. Meaning that if the
samples did not undergo that period of degradation then the ultimate tensile strength at 24
hours would be considerably higher. Each of the three agents exhibit similar effects on
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the structure of the leaflets themselves. This common effect has carried over into the
mechanical properties as well. Each of the agents affects the mechanical properties in the
same way and at comparable rates.
While the results obtained were not exactly what was expected, they actually
provide some helpful information.

The elastic modulus was measured during the

inelastic phase of the stress strain curve. This phase corresponds to diastole. Since no
trend was found in the increase of the elastic modulus or the ultimate tensile strength of
the samples, this indicates that concentration does not affect the mechanical properties of
the heart valve leaflets. This also indicates that the agents do not interfere with diastole
or cause valve prolapse. Since the agents contribute to contraction of the leaflets, it was
thought that the agents could potentially alter the mechanical properties, and in turn cause
valve prolapse. This study has shown that this is not supported by the concentration
dependent reactions. However, the effect over time has been significant. The study
showed that the concentration of the agents did not matter but the length of exposure to
the agents did make a significant difference.

Summary
In general we found that endothelin I, angiotension II, and 5-HT did not produce
concentration dependent changes in the elastic modulus or the ultimate tensile strength.
We did find that the elastic modulus after 24 hours of exposure the elastic modulus was
significantly larger than at 0.5 or 6 hours and that the ultimate tensile strength was
significantly different between each exposure time. After viewing the H and E slides it
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was determined that the changes in the elastic modulus and the ultimate tensile strength
could be attributed to the changes in the collagen break down and synthesis.

Limitations
One limitation of this experiment was that the samples were tested unaxially. The
samples were each tested in the radial direction. In vivo the leaflets undergo stress and
strain in both the radial and circumferential directions. Since the machines used can only
test in one direction at a time the radial direction was chosen because of the amount of
stress and deformation which the valve undergoes in the radial direction. Since the
collagen in the fibrosa is arranged parallel to the free edge, the measurements made in the
circumferential direction should vary greatly from those in the radial direction. The
collagen in the fibrosa is considered to maintain the mechanical properties as the strain
increases.
Another limitation of the study was the source of the valves. The valves were
received with no knowledge of the porcine specimens. One valve that was sent was not
used due to defects. However, there was not a way for us to determine the age, gender,
size and health of the pigs. Each of these factors can influence the condition of the heart
and the valves themselves. This lack of information and unknown variability can also be
cited as a potential source for the variability in the data collected.

Future Research
The results of this study open the doors for future studies. One of the first and
most obvious is to conduct a very similar study in the circumferential direction and
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compare those results to the ones found in the radial direction. This would allow a better
understanding of the mechanical effect of the vasoactive agents on the entire leaflet.
Another area which can be explored is the mechanism by which the agents work over
time. In this study we observed that the collagen appears to be broken down within the
first 6hours in solution and then reformed within the first 24 hours. This area of the study
leaves several questions to be answered. One of the first things to be determined is
whether or not the collagen breaks down or not. If it does not then it needs to be
determined if a rebuilding occurs, and for what duration. Answering these questions can
lead a understanding of how the increased collagen synthesis can be halted. Another
aspect to be researched is what, if any effect the increase in collagen synthesis has on the
overall function of the valve over time. One area of weakness in this study that can be
addressed in future work is that the samples were allowed to simply sit in solution. No
cyclic forces were maintained on the samples as would occur in vivo. Providing a
constant cyclic strain on the leaflets may affect the manner in which the collagen
degrades and also the manner in which the collagen rebuilds. Nutrient rich media will
also provide the necessary building blocks for the production of collagen and in turn lead
to more drastic changes in the mechanical properties over time.
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APPENDIX A
STRESS STRAIN CURVES FOR CONTROL
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Stress vs. Strain Endothelin I 5e-7
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Stress vs. Strain 5-HT 5e-5
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Stress vs. Strain 0.5 Hour Exposure to KCl
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